Community Oncology Connections™: How Can We Optimize the Use of Oral SERDs in the Community Oncology Setting? Best Practices for HR+/HER2- Breast Cancer
Wednesday, September 9, 2026
5:15 PM - 6:15 PM ET
This online, CME-certified Community Oncology Connections – How Can We Optimize the Use of Oral SERDs in the Community Oncology Setting? Best Practices for HR+/HER2- Breast Cancer, will bring together expert faculty to review the key recent findings and discuss their potential implications for community oncologists.
Community Oncology Connections™: Advancing Precision Care in HER2-Positive Gastroesophageal Adenocarcinomas: A Collective Curriculum on the Integration of Novel Bispecific Antibody Therapy
Wednesday, September 30, 2026
5:15 PM - 6:15 PM ET
In this series of live, virtual webcasts, experts in the management of esophagogastric adenocarcinoma discuss the evaluation and treatment of HER2-positive disease across the treatment continuum.
Community Oncology Connections™: Immunotherapy Across the SCLC Continuum: Optimizing Treatment Pathways from Limited-Stage Through Relapsed Disease
Wednesday, December 9, 2026
5:15 PM - 6:30 PM ET
This program pairs an academic SCLC expert with a community oncologist to discuss the latest advances and enable the integration of immunotherapy across the SCLC continuum into community practice.